Bioresorbable vascular scaffolds (BRS) represent a novel approach to provide transient
vessel support to drug-delivery capability without the long-term limitations of metallic drug …

Bioresorbable scaffolds (BRS) have been advocated as the 'fourth revolution'in
interventional cardiology because they could provide temporary scaffolding and then …

Bioresorbable scaffolds have the potential to introduce a paradigm shift in interventional
cardiology, a true anatomical and functional “vascular restoration” instead of an artificial stiff …

Background Coronary stents are routinely placed in the treatment and prophylaxis of
coronary artery disease (CAD). Current coronary stent designs are prone to developing …

Aims: Invasive imaging modalities have shown restoration of vasomotion, prevention of
restenosis and, most importantly, increase in lumen area between six months and two years …

Optical coherence tomography (OCT) has opened new horizons for intravascular coronary
imaging. It utilizes near-infrared light to provide a microscopic insight into the pathology of …

Coronary angioplasty initially employed balloon dilatation only. This technique
revolutionized the treatment of coronary artery disease, although outcomes were …

Aims: The Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) represents an
important advance in percutaneous coronary intervention (PCI) technology. With increasing …

The optimal duration and type of antiplatelet therapy after implantation of a drug-eluting stent
(DES) remains uncertain. At the time of the first-in-man implantation of the sirolimus DES in …

The advent of plain-old balloon an-gioplasty (POBA), first introduced by Andreas Grüntzig in
1977, revolutionised the treatment of coronary artery disease. Significant coronary lesions …